Overcoming the challenges of cancer diagnostics development
This article was originally published in Clinica
Executive Summary
Cancer diagnostics provide a promising future for unraveling the mystery of one of the leading killer diseases and helping to better detect and treat it. However, companies are currently facing a number of potential challenges when developing cancer diagnostic assays and proving clinical utility. In this article, Dr Hua Gong of D-Target details these challenges and how the industry is working to overcome them